Peter Richard Strack,Robert Booher,Venkataraman Sriram,Joseph H. Phillips
申请号：
US14912771
公开号：
US09827309B2
申请日:
2014.08.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
